Assessing Pulse Biosciences (PLSE) Valuation After Upcoming nPulse Cardiac Study Data Presentation

Simply Wall St.01-09

AdvertisementWhy the latest nPulse study update matters for Pulse Biosciences (PLSE) Pulse Biosciences (PLSE) just flagged a fresh catalyst, with late-breaking 6- and 12-month data from its first-in-...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2602377705?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-01-09 22:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602377705","market":"sg","top_or_hot":-1,"title":"Assessing Pulse Biosciences (PLSE) Valuation After Upcoming nPulse Cardiac Study Data Presentation","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementWhy the latest nPulse study update matters for Pulse Biosciences (PLSE) Pulse Biosciences (PLSE) just flagged a fresh catalyst, with late-breaking 6- and 12-month data from its first-in-...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/assessing-pulse-biosciences-plse-valuation-after-upcoming-np\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Pulse Biosciences (PLSE) Valuation After Upcoming nPulse Cardiac Study Data Presentation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Pulse Biosciences (PLSE) Valuation After Upcoming nPulse Cardiac Study Data Presentation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-09 22:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/assessing-pulse-biosciences-plse-valuation-after-upcoming-np><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementWhy the latest nPulse study update matters for Pulse Biosciences (PLSE) Pulse Biosciences (PLSE) just flagged a fresh catalyst, with late-breaking 6- and 12-month data from its first-in-...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/assessing-pulse-biosciences-plse-valuation-after-upcoming-np\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PLSE","symbol_name":"Pulse Biosciences, Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/assessing-pulse-biosciences-plse-valuation-after-upcoming-np","article_id":"2602377705","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/assessing-pulse-biosciences-plse-valuation-after-upcoming-np","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2602377705","pubTimestamp":1767968514,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Why the latest nPulse study update matters for Pulse Biosciences (PLSE)\nPulse Biosciences (PLSE) just flagged a fresh catalyst, with late-breaking 6- and 12-month data from its first-in-human nPulse Cardiac Catheter Ablation System study set for presentation at the 31st Annual AF Symposium 2026.\nSee our latest analysis for Pulse Biosciences.\nThe upcoming AF Symposium data drop lands after a mixed year for investors, with a 9.93% year to date share price return to US$14.72, a 16.36% 3 month...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"PLSE":"Pulse Biosciences, Inc.","BK4082":"医疗保健设备"},"translate_title":"在即将发布的nPulse心脏研究数据展示后评估Pulse Biosciences(PLSE)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PLSE":1.5},"content_text":"AdvertisementWhy the latest nPulse study update matters for Pulse Biosciences (PLSE) Pulse Biosciences (PLSE) just flagged a fresh catalyst, with late-breaking 6- and 12-month data from its first-in-human nPulse Cardiac Catheter Ablation System study set for presentation at the 31st Annual AF Symposium 2026. See our latest analysis for Pulse Biosciences. The upcoming AF Symposium data drop lands after a mixed year for investors, with a 9.93% year to date share price return to US$14.72, a 16.36% 3 month share price decline, and a very large 3 year total shareholder return that contrasts with a 20.13% 1 year total shareholder return decline. This hints that momentum has cooled recently even as interest around nPulse builds. If cardiac ablation is on your radar and you are comparing other potential ideas in the sector, it could be a good moment to scan healthcare stocks for additional candidates. With PLSE trading at US$14.72, a 9.93% year-to-date return and a very large 3 year total shareholder return sit beside a 20.13% 1 year decline. Is this weakness a chance to buy, or is future growth already priced in? Price to book of 10.8x: Is it justified? On a P/B of 10.8x at a last close of US$14.72, Pulse Biosciences trades well above both its industry and peer averages. This points to a rich valuation relative to current fundamentals. P/B compares the company’s market value to its net assets. A 10.8x multiple suggests investors are paying more than ten times the book value for each share, which can sometimes reflect expectations for strong future revenue growth in early stage businesses. Here, that premium sits against very limited revenue of US$86K, ongoing losses and forecasts that earnings may decline on average over the next 3 years. The current P/B level therefore implies the market is assigning a substantial value to future potential rather than present profitability. Compared with the US Medical Equipment industry average P/B of 2.6x and a peer average of 2.5x, PLSE’s 10.8x multiple is more than four times higher. This is a clear signal that the shares are priced well above sector norms. See what the numbers say about this price — find out in our valuation breakdown. Result: Price-to-book of 10.8x (OVERVALUED) However, the valuation premium sits against revenue of just US$86K and a net loss of US$74.733m, so any setback in nPulse progress could quickly test sentiment. Find out about the key risks to this Pulse Biosciences narrative.  Build Your Own Pulse Biosciences Narrative If you see the numbers differently or simply prefer to test your own assumptions, you can build a custom view in just a few minutes by starting with Do it your way. A great starting point for your Pulse Biosciences research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision. Looking for more investment ideas? If PLSE is only one piece of your watchlist, now is the time to widen your search with data backed stock ideas tailored to different themes.  Spot potential value candidates by scanning these 877 undervalued stocks based on cash flows to find shares trading below what their cash flows may imply. Back emerging technology trends by reviewing these 28 AI penny stocks that focus on businesses tied to artificial intelligence developments. Lean into income focused ideas by checking out these 11 dividend stocks with yields > 3% that highlight companies with dividend yields above 3%.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602377705","isCrawlerRequest":true}